Nicolas Raposo1,2, Mélanie Planton3,4, Pierre Payoux4,5, Patrice Péran4, Jean François Albucher3,4, Lionel Calviere3,4, Alain Viguier3,4, Vanessa Rousseau6, Anne Hitzel4,5, François Chollet3,4, Jean Marc Olivot3,4, Fabrice Bonneville4,7, Jérémie Pariente3,4. 1. Department of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France. raposo.n@chu-toulouse.fr. 2. Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France. raposo.n@chu-toulouse.fr. 3. Department of Neurology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Place Baylac, 31059, Toulouse Cedex 9, France. 4. Toulouse NeuroImaging Center, Université de Toulouse, Inserm, UPS, Toulouse, France. 5. Department of Nuclear Medicine, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. 6. Department of Epidemiology, Centre Hospitalier Universitaire de Toulouse, Toulouse, France. 7. Department of Neuroradiology, Hôpital Pierre-Paul Riquet, Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
Abstract
PURPOSE: Enlarged perivascular spaces in the centrum semiovale (CSO-EPVS) have been linked to cerebral amyloid angiopathy (CAA). To get insight into the underlying mechanisms of this association, we investigated the relationship between amyloid-β deposition assessed by 18F-florbetapir PET and CSO-EPVS in patients with acute intracerebral hemorrhage (ICH). METHODS: We prospectively enrolled 18 patients with lobar ICH (suggesting CAA) and 20 with deep ICH (suggesting hypertensive angiopathy), who underwent brain MRI and 18F-florbetapir PET. EPVS were assessed on MRI using a validated 4-point visual rating scale in the centrum semiovale and the basal ganglia (BG-EPVS). PET images were visually assessed, blind to clinical and MRI data. We evaluated the association between florbetapir PET positivity and high degree (score> 2) of CSO-EPVS and BG-EPVS. RESULTS: High CSO-EPVS degree was more common in patients with lobar ICH than deep ICH (55.6% vs. 20.0%; p = 0.02). Eight (57.1%) patients with high CSO-EPVS degree had a positive florbetapir PET compared with 4 (16.7%) with low CSO-EPVS degree (p = 0.01). In contrast, prevalence of florbetapir PET positivity was similar between patients with high vs. low BG-EPVS. In multivariable analysis adjusted for age, hypertension, and MRI markers of CAA, florbetapir PET positivity (odds ratio (OR) 6.44, 95% confidence interval (CI) 1.32-38.93; p = 0.03) was independently associated with high CSO-EPVS degree. CONCLUSIONS: Among patients with spontaneous ICH, high degree of CSO-EPVS but not BG-EPVS is associated with amyloid PET positivity. The findings provide further evidence that CSO-EPVS are markers of vascular amyloid burden that may be useful in diagnosing CAA.
PURPOSE: Enlarged perivascular spaces in the centrum semiovale (CSO-EPVS) have been linked to cerebral amyloid angiopathy (CAA). To get insight into the underlying mechanisms of this association, we investigated the relationship between amyloid-β deposition assessed by 18F-florbetapir PET and CSO-EPVS in patients with acute intracerebral hemorrhage (ICH). METHODS: We prospectively enrolled 18 patients with lobar ICH (suggesting CAA) and 20 with deep ICH (suggesting hypertensive angiopathy), who underwent brain MRI and 18F-florbetapir PET. EPVS were assessed on MRI using a validated 4-point visual rating scale in the centrum semiovale and the basal ganglia (BG-EPVS). PET images were visually assessed, blind to clinical and MRI data. We evaluated the association between florbetapir PET positivity and high degree (score> 2) of CSO-EPVS and BG-EPVS. RESULTS: High CSO-EPVS degree was more common in patients with lobar ICH than deep ICH (55.6% vs. 20.0%; p = 0.02). Eight (57.1%) patients with high CSO-EPVS degree had a positive florbetapir PET compared with 4 (16.7%) with low CSO-EPVS degree (p = 0.01). In contrast, prevalence of florbetapir PET positivity was similar between patients with high vs. low BG-EPVS. In multivariable analysis adjusted for age, hypertension, and MRI markers of CAA, florbetapir PET positivity (odds ratio (OR) 6.44, 95% confidence interval (CI) 1.32-38.93; p = 0.03) was independently associated with high CSO-EPVS degree. CONCLUSIONS: Among patients with spontaneous ICH, high degree of CSO-EPVS but not BG-EPVS is associated with amyloid PET positivity. The findings provide further evidence that CSO-EPVS are markers of vascular amyloid burden that may be useful in diagnosing CAA.
Authors: Gargi Banerjee; Hee Jin Kim; Zoe Fox; H Rolf Jäger; Duncan Wilson; Andreas Charidimou; Han Kyu Na; Duk L Na; Sang Won Seo; David J Werring Journal: Brain Date: 2017-04-01 Impact factor: 13.501
Authors: Andreas Charidimou; Jennifer Linn; Meike W Vernooij; Christian Opherk; Saloua Akoudad; Jean-Claude Baron; Steven M Greenberg; Hans Rolf Jäger; David J Werring Journal: Brain Date: 2015-06-26 Impact factor: 13.501
Authors: Andreas Charidimou; Zane Jaunmuktane; Jean-Claude Baron; Matthew Burnell; Pascale Varlet; Andre Peeters; John Xuereb; Rolf Jäger; Sebastian Brandner; David J Werring Journal: Neurology Date: 2013-11-27 Impact factor: 9.910
Authors: Susanne J van Veluw; Geert Jan Biessels; Willem H Bouvy; Wim Gm Spliet; Jaco Jm Zwanenburg; Peter R Luijten; Eric A Macklin; Annemieke Jm Rozemuller; M Edip Gurol; Steven M Greenberg; Anand Viswanathan; Sergi Martinez-Ramirez Journal: J Cereb Blood Flow Metab Date: 2015-12-07 Impact factor: 6.200
Authors: M Edip Gurol; J Alex Becker; Panagiotis Fotiadis; Grace Riley; Kristin Schwab; Keith A Johnson; Steven M Greenberg Journal: Neurology Date: 2016-09-07 Impact factor: 9.910
Authors: Valentina Perosa; Jan Oltmer; Leon P Munting; Whitney M Freeze; Corinne A Auger; Ashley A Scherlek; Andre J van der Kouwe; Juan Eugenio Iglesias; Alessia Atzeni; Brian J Bacskai; Anand Viswanathan; Matthew P Frosch; Steven M Greenberg; Susanne J van Veluw Journal: Acta Neuropathol Date: 2021-12-20 Impact factor: 15.887
Authors: Yang Gao; Weiping Deng; Jialan Sun; Dongqi Yue; Bei Zhang; Yulan Feng; Jun Han; Fanxia Shen; Jin Hu; Yi Fu Journal: Front Neurol Date: 2022-05-23 Impact factor: 4.086